$0.43
+ $0.05 (13.16%)
End-of-day quote: 05/01/2024
NasdaqCM:BCLI

Brainstorm Cell Therapeutics Stock Price

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Market Cap
0.04B
Price-to-book Ratio
0
Earnings
05/10/2024
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
0.29
Short Interest
4.15%
Forecast 1Y
0.00%
Analyst Price Target
$0.50
LTG 5Y
0.00%
52 week range
$0.13 - $3.34